| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AHI1
|
Abelson helper integration site 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APOA1
|
apolipoprotein A-I
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
AURKA
|
aurora kinase A
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
CALR
|
calreticulin
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBX5
|
chromobox homolog 5
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CD24
|
CD24 molecule
|
|
CD274
|
CD274 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTGF
|
connective tissue growth factor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EPOR
|
erythropoietin receptor
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FH
|
fumarate hydratase
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS2
|
hyaluronan synthase 2
|
|
HFE
|
hemochromatosis
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNG
|
interferon, gamma
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL1B
|
interleukin 1, beta
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MIR375
|
microRNA 375
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
NIN
|
ninein (GSK3B interacting protein)
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
OSM
|
oncostatin M
|
|
OSMR
|
oncostatin M receptor
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PML
|
promyelocytic leukemia
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RET
|
ret proto-oncogene
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
SET
|
SET nuclear proto-oncogene
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A3
|
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
|
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
THPO
|
thrombopoietin
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
